Mackenzie Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$303M Buy
2,517,435
+1,052,450
+72% +$122M 0.36% 62
2025
Q4
$155M Buy
1,464,985
+290,269
+25% +$27.2M 0.18% 109
2025
Q3
$98.6M Buy
1,174,716
+111,326
+10% +$9.17M 0.12% 157
2025
Q2
$84.2M Sell
1,063,390
-110,544
-9% -$8.79M 0.11% 171
2025
Q1
$105M Sell
1,173,934
-602,919
-34% -$56.3M 0.15% 143
2024
Q4
$177M Sell
1,776,853
-512,124
-22% -$52.8M 0.24% 104
2024
Q3
$260M Sell
2,288,977
-50,129
-2% -$5.96M 0.36% 76
2024
Q2
$290M Buy
2,339,106
+149,979
+7% +$19.3M 0.43% 63
2024
Q1
$289M Buy
2,189,127
+193,843
+10% +$23.9M 0.42% 62
2023
Q4
$218M Buy
1,995,284
+299,077
+18% +$31M 0.33% 80
2023
Q3
$173M Sell
1,696,207
-65,907
-4% -$7.1M 0.29% 90
2023
Q2
$201M Sell
1,762,114
-775,785
-31% -$88.1M 0.31% 84
2023
Q1
$270M Buy
2,537,899
+47,005
+2% +$5.07M 0.42% 59
2022
Q4
$276M Buy
2,490,894
+12,531
+0.5% +$1.28M 0.46% 55
2022
Q3
$213M Buy
2,478,363
+99,935
+4% +$8.92M 0.37% 68
2022
Q2
$217M Buy
2,378,428
+230,261
+11% +$20.4M 0.35% 65
2022
Q1
$176M Buy
2,148,167
+2,460
+0.1% +$194K 0.24% 104
2021
Q4
$164M Buy
2,145,707
+160,345
+8% +$12.8M 0.22% 115
2021
Q3
$149M Buy
1,985,362
+72,702
+4% +$5.53M 0.21% 115
2021
Q2
$149M Sell
1,912,660
-134,754
-7% -$10M 0.21% 118
2021
Q1
$151M Sell
2,047,414
-213,222
-9% -$15.7M 0.23% 108
2020
Q4
$176M Sell
2,260,636
-156,645
-6% -$12M 0.38% 79
2020
Q3
$191M Buy
2,417,281
+479,175
+25% +$37.5M 0.48% 57
2020
Q2
$143M Sell
1,938,106
-8,547
-0.4% -$643K 0.38% 78
2020
Q1
$143M Buy
1,946,653
+564,489
+41% +$44.4M 0.46% 57
2019
Q4
$120M Buy
1,382,164
+129,866
+10% +$10.7M 0.29% 90
2019
Q3
$101M Buy
1,252,298
+11,050
+0.9% +$886K 0.26% 97
2019
Q2
$99.3M Buy
1,241,248
+739,024
+147% +$56.6M 0.26% 99
2019
Q1
$39.9M Sell
502,224
-594,720
-54% -$44.5M 0.1% 196
2018
Q4
$80M Sell
1,096,944
-175,743
-14% -$12.4M 0.21% 113
2018
Q3
$86.1M Sell
1,272,687
-704,389
-36% -$44.9M 0.21% 123
2018
Q2
$115M Sell
1,977,076
-3,817,922
-66% -$215M 0.29% 91
2018
Q1
$301M Sell
5,794,998
-431,331
-7% -$23.3M 0.77% 30
2017
Q4
$334M Buy
6,226,329
+6,207,678
+33,283% +$344M 0.81% 29
2017
Q3
$1.14M Buy
18,651
+661
+4% +$40.1K 0.01% 439
2017
Q2
$1.1M Buy
17,990
+1,191
+7% +$72.5K 0.01% 440
2017
Q1
$1.02M Sell
16,799
-4,326
-20% -$262K 0.01% 459
2016
Q4
$1.19M Buy
21,125
+943
+5% +$55.2K 0.01% 427
2016
Q3
$1.2M Sell
20,182
-152,831
-88% -$8.94M 0.01% 394
2016
Q2
$9.51M Buy
173,013
+15,437
+10% +$822K 0.05% 253
2016
Q1
$7.96M Sell
157,576
-10,697
-6% -$524K 0.07% 222
2015
Q4
$8.48M Buy
168,273
+12,451
+8% +$628K 0.05% 261
2015
Q3
$7.34M Buy
155,822
+10,652
+7% +$566K 0.04% 259
2015
Q2
$7.89M Sell
145,170
-149
-0.1% -$8.36K 0.04% 272
2015
Q1
$7.97M Sell
145,319
-1,144
-0.8% -$64.8K 0.04% 275
2014
Q4
$7.94M Buy
146,463
+8,226
+6% +$458K 0.04% 275
2014
Q3
$7.82M Sell
138,237
-15,152
-10% -$851K 0.04% 272
2014
Q2
$8.47M Buy
153,389
+24,630
+19% +$1.34M 0.04% 273
2014
Q1
$6.97M Sell
128,759
-7,282
-5% -$377K 0.03% 291
2013
Q4
$6.5M Sell
136,041
-1,231
-0.9% -$56.3K 0.03% 282
2013
Q3
$6.24M Buy
137,272
+14,067
+11% +$642K 0.03% 283
2013
Q2
$5.46M Buy
+123,205
New +$5.5M 0.03% 309

Other funds holding MRK

Mackenzie Financial's MRK Position: Q1 2026 in Review

Mackenzie Financial increased its Merck (MRK) stake by 72% in Q1 2026, buying an estimated $122M and bringing the position to 2,517,435 shares worth $303M. The position accounts for 0.36% of the portfolio, ranked #62.

Mackenzie Financial first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $334M in Q4 2017. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mackenzie Financial held 2,517,435 shares of Merck worth $303M as of Q1 2026.
  • Mackenzie Financial bought 1,052,450 Merck shares in Q1 2026, an estimated $122M.
  • Merck made up 0.36% of Mackenzie Financial's portfolio in Q1 2026, its #62 holding.
  • Mackenzie Financial first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Mackenzie Financial's Merck position peaked at $334M in Q4 2017.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.